omics data integration

Cambridge Data Science LLC develops AI/ML-driven computational biology and cancer genomics solutions, integrating omics data and predictive modeling to support biotech and pharmaceutical companies in drug discovery and precision medicine.

AI/MLcancer genomicscomputational biologypredictive modeling

Emtherapro provides a next generation precision medicine enablement solution for neurodegenerative diseases, empowering biotech, life sciences and pharmaceutical companies to develop diagnostics and therapies. Anchored in proteomics, it integrates clinical, pathological, genetic and other omics data to advance biomarker discovery and validation for risk profiling, diagnosis, monitoring, prognosis and safety.

Read more

AIbiomarker identification and validationdrug engagement and dosage optimizationmachine learningMoA analysisparticipant screeningpre-clinical optimizationproteomicssystems biologytarget identification and validation